The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
June 20th 2025
The FDA approves dupilumab as the first targeted treatment for bullous pemphigoid, offering hope for patients with this debilitating skin condition.
Pharmacy Focus Podcast: Move the Needle Monday- Episode 2
October 11th 2021The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.
Listen
Expert: Pfizer Requests the Approval of COVID-19 Vaccine for Ages 5 to 11
October 8th 2021Anna Legreid-Dopp, PharmD, Senior Director of Clinical Guidelines and Quality Improvement at the American Society of Health-System Pharmacists discusses Pfizer’s request to approve their COVID-19 vaccine for children 5 to 11.
Watch
FDA Approves Avacopan for Treatment of ANCA-Associated Vasculitis
October 8th 2021Avacopan (Tavneos, ChemoCentryx) met its primary endpoints of disease remission at 26 weeks and sustained remission at 52 weeks during a phase 3 trial in patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
Read More
Kelan Thomas, PharmD, MS, associate professor of clinical sciences at Touro University California College of Pharmacy, discusses key points to consider regarding co-administration of MDMA, psilocybin, and ketamine with psychiatric medications, such as SSRI or SNRI antidepressants.
Watch
Study: Ketone Supplement May Be Therapeutic for Boosting Brain Function in Obesity
October 7th 2021The researchers also demonstrated that ketone supplements may be a novel therapy for protecting and improving brain health in people with obesity who are at risk of developing neurocognitive impairment.
Read More